Director for Haematology Research and Development, University Hospital of Wales, Cardiff and Vale University Health Board
Consultant Haematologist and Clinical Lead for Myeloma, University Hospital of Wales
Honorary Senior Research Fellow, Cardiff University

Dr Bygrave graduated from the University of Wales College of Medicine at Cardiff University, including completing a laboratory-based research MPhil on receptor tyrosine kinase inhibition in the stromal microenvironment.

Ceri established the myeloma service at the University Hospital of Wales and has delivered a broad portfolio of myeloma trials. Her clinical interests are in novel techniques to measure minimal residual disease (MRD) including imaging and mass spectrometry. 

With a focus on real-world data, Ceri established the Wales National Myeloma Dashboard and enabled Cardiff to become an Honeur database site. Ceri is a member of the UK Myeloma Research Alliance and is Chair of the UK Myeloma Society.